1 |
CH0113817123 |
Bellevue Biotech DT CHF |
+0,34 % |
+18,48 % |
-0,11 |
2 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-6,65 % |
+17,69 % |
-0,51 |
3 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-6,53 % |
+16,79 % |
-0,53 |
4 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-2,74 % |
+18,53 % |
-0,27 |
5 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-2,96 % |
+18,51 % |
-0,29 |
|
39 |
LU1269737059 |
Candriam Equities L Biotechnology, I - Capitalisation |
-6,17 % |
+17,66 % |
-0,48 |
|
73 |
LU1803069274 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) EUR-H1 |
-12,58 % |
+19,59 % |
-0,76 |
74 |
LU0774687577 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP |
-13,29 % |
+18,32 % |
-0,85 |
75 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-14,74 % |
+19,63 % |
-0,87 |
76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-32,28 % |
+30,22 % |
-1,14 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-32,35 % |
+30,21 % |
-1,15 |